Questions
SARS-CoV-2 — Questions
Study questions about SARS-CoV-2 — exam-style, clinical-scenario and FAQ.
Mock Exam mode
Sit this set one question at a time. Multiple-choice questions mark themselves; written questions reveal a tickable mark scheme so you can score your own answer. You get a combined score at the end.
1 questions: 0 MCQ, 1 written.
High prioritySAQState the vaccine platform or type for each of the following: the Pfizer- BioNTech COVID-19 vaccine, Cervarix, the annual inactivated influenza vaccine, the mumps vaccine, and Shingrix. [5]
Model answer
- Pfizer-BioNTech COVID-19 vaccine (Comirnaty): mRNA vaccine in a lipid nanoparticle, encoding the pre-fusion spike protein.
- Cervarix: virus-like particle (HPV L1) vaccine, bivalent (types 16 and 18), with the AS04 adjuvant.
- Annual inactivated influenza vaccine: inactivated (killed) vaccine, usually split or subunit, grown in eggs or cell culture.
- Mumps vaccine: live attenuated vaccine (the Jeryl Lynn strain), given within MMR.
- Shingrix: recombinant protein subunit vaccine (varicella-zoster glycoprotein E) with the AS01B adjuvant.